Dear Voornaam This week, we celebrated the first anniversary of our innovation arm, Cancer Research Horizons – and what a year it’s been. Cancer Research Horizons unites our drug discovery labs, tech platforms, biology network and commercial activities within a single organisation to advance the best research and cutting-edge approaches towards novel therapeutic innovation programmes, commercial partnerships and clinical development. We also set up Cancer Research Horizons to help researchers along their translational journey from early drug discovery to clinical or commercial application, by providing support and direction with some of the trickier aspects, such as legal affairs, business development and sourcing financing. Our first year saw many of you participating in our entrepreneurial programmes to acquire the key skills and receive bespoke advice to maximise the potential of your research and connect with other scientific entrepreneurs. I’m pleased to share that our newest programmes, Oncostars and Oncology Development Programme 2, are now open for applications – read on for more information. Thank you for being a part of this over the last year. Keep in touch with our teams and follow Cancer Research Horizons on LinkedIn and Twitter to hear the latest updates and opportunities, so your research also has the best path to reach patients. Kind regards, Iain Foulkes Executive Director Research & Innovation CEO Cancer Research Horizons Cancer Research UK |
|
---|
|
---|
|
|
Funding & Research Opportunities |
|
---|
|
---|
| Applications accepted all-year round |
|
---|
|
---|
| Applications accepted all-year round |
|
---|
|
---|
| Applications accepted all-year round |
|
---|
|
---|
|
|
SPARK YOUR ENTREPRENEURIAL SPIRIT WITH ONCOSTARS The Panacea OncoStars Programme provides top-class entrepreneurial training and will inspire you to think about your cancer research from a patient impact perspective, understand the research translation ecosystem and support the commercial development of your bold and innovative vision. The programme is aimed at everyone working on the diagnosis, treatment or prevention of cancer. The best companies will be offered a place in our more advanced programme, Develop AW23/24, where they’ll have the opportunity to win a non-dilutive prize worth £100k. Apply by 21 May to get your research out of the lab. |
|
---|
| DEVELOP YOUR ONCOLOGY ASSETS FOR INVESTMENT Created in collaboration with Lean Life Science, the Oncology Development Programme is an accelerator that guides you through the pathway of identifying, translating and scaling your oncology innovation. Part 3 of the accelerator will help you build a commercial strategy and business model to ensure the successful development of your assets and attract potential funding. Apply by 21 May for the opportunity to take part in this three-month intensive programme and engage with CRO delivery partners and pitch to investors. |
|
---|
|
---|
|
|
ONE MONTH TO GO UNTIL OUR RADIATION RESEARCH CONFERENCE If you’re interested in translational radiobiology, join us in Glasgow in June to hear from Charlotte Coles (University of Cambridge) and Graeme Hewitt (King's College London), who will chair a session on how radiation biology is informing the design of radiotherapy clinical trials. Navita Somaiah (The Institute of Cancer Research), Chris Jones (University of Cambridge), Ester Hammond (University of Oxford) and Anthony Chalmers (University of Glasgow) will present recent findings, followed by a debate-provoking discussion. Our three-day event, run in partnership with the Association for Radiation Research, is packed with opportunities to explore some of the biggest and most interesting challenges in radiotherapy. |
|
---|
|
---|
|
|
PRESENT YOUR WORK AT OUR CHILDREN’S AND YOUNG PEOPLE’S CANCER RESEARCH CONFERENCE Could you apply your research to children’s and young people’s cancer? Submit an abstract to showcase your work at our first cancer research conference for this group taking place in November. If you’re an early career researcher, you’ll have the chance to give a proffered talk alongside expert researchers. To be considered for a poster session or proffered talk, submit your abstract by 6 September. |
|
---|
| WEBINAR ON MULTI-DISCIPLINARY APPROACHES TO CANCER CLINICAL TRIALS Are you a nurse working in a cancer setting and want to understand the role you can play in cancer research? RCNi's webinar on 9 May will demystify clinical trials and show the impact nurses can have to benefit patients, processes and clinical outcomes. The webinar will address key topics around embedding research into standard care, from increasing trial accessibility for young people to overcoming the challenges of cancer trials and the practicalities of balancing clinical care and research responsibilities. |
|
---|
|
---|
|
|
SEX, INTIMACY AND CANCER – THAT CANCER CONVERSATION Any cancer diagnosis regardless of its type can have an impact on a person's sexual wellbeing and sexual confidence and can detract from the enjoyment that they experience sexually, says Isabel White, a cancer and psychosexual nurse. We sat down with Isabel, Brian Lobel (co-founder of Sex with Cancer) and Tara to talk about sexual wellbeing for those affected by cancer in the latest episode of our podcast series That Cancer Conversation. Hear Isabel’s advice on talking about sexual wellbeing with health professionals, how Brian's online initiative creates a safe space for open conversations and how Tara approached sex and intimacy after her cancer treatment. |
|
---|
|
---|
|
|
ANDREW PORTER’S TOP TIPS ON REFERENCING IN RESEARCH A surprisingly large number of papers continue to be cited after they have been retracted. In his latest blogpost for our series on research integrity, Andrew Porter (Research Integrity and Training Adviser at the Cancer Research UK Manchester Institute) shares bite-sized ways to follow good practice when using references. Find out how you can add flavour to your references, the best strategies to avoid ‘zombie papers’ and key tools to manage your citations. |
|
---|
| JOIN THE RESEARCH CULTURE AND PRACTICE FORUM Universities UK is hosting a free online event on 13–14 June to explore positive research culture and practice. Anyone involved in research is welcome to attend and join in the discussions on topics ranging from sustainable research to integrity, knowledge exchange, culture and wellbeing. |
|
---|
|
---|
|
|
MEET THE CHAIRS OF OUR EARLY DETECTION OF CANCER CONFERENCE Our international early detection of cancer event is taking shape, with the latest chairs confirmed as: Kate Brain (Cardiff University) and Carmen Guerra (University of Pennsylvania) to chair a session on inequalities in cancer detection and diagnosis Sam Janes (University College London) and Irene Ghobrial (Harvard University) are shaping a session on understanding pre-cancers to enable early detection Matthew Thompson (University of Washington) and Claude Chelala (Queen Mary University of London) will explore multicancer early detection – beyond ctDNA Sapna Syngal (Harvard Medical School) and Yoryos Lyratzopoulos (University College London) on risk stratification to inform early detection Larry Kessler (University of Washington) will lead a panel discussion exploring the health economics of early detection And Jon Emery (University of Melbourne) will lead a panel on ‘Why haven’t the technological and regulatory advances from our learnings of the COVID-19 pandemic accelerated research in the cancer early detection research field?’ Join us on 10–12 October in London for three days of discussions and networking opportunities with peers and experts from across the globe. |
|
---|
|
---|
|
|
| Online 12:00 PM 09 May 2023 |
|
---|
|
---|
| Online 10:00 AM 31 May 2023 |
|
---|
|
---|
| Online 4:00 PM 05 July 2023 |
|
---|
|
---|
| Online 4:00 PM 27 September 2023 |
|
---|
|
---|
| London, UK 10 October 2023 |
|
---|
|
---|
| London, UK 14 November 2023 |
|
---|
|
---|
|
|
WHAT DID YOU THINK OF THIS EMAIL? We're always looking for ways to improve. Please give us your feedback by clicking below and leaving a comment. |
|
---|
|
---|
|
|
Been forwarded this email? Subscribe to our newsletter to stay up-to-date. |
---|
| |
---|
|
|
|